semaglutide after kidney transplant Semaglutide: A New Era in Health Ozempic Slows Kidney Disease, Now

But he knows thats just not always realistic

Losing weight also may result in saggy skin and muscle loss

Ethics declarations Conflict of Interest Mohamed Elnaggar has received funds for talks, research grants, and advisory boards from Abbott, Amarin, Amgen, AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, Eli Lilly, Menarini, Novartis, Novo Nordisk, and Sanofi

Tapering is not the right approach for everyone, and the plan should always be guided by a prescribing clinician

As with any medication, individual responses can vary, and its use should be carefully monitored under the guidance of a healthcare professional